Valerie Roobrouck

Valerie Roobrouck serves as Biomarker Lead in Immuno-oncology at iTeos Therapeutics since December 2022, previously working as Senior Scientist at ReGenesys BV from January 2015 to December 2022, where responsibilities included leading a preclinical team focused on cell therapy and managing R&D programs involving MultiStem® in Immunology/Transplantation. Prior to this, from January 2006 to December 2014, Valerie Roobrouck was a Postdoctoral researcher at KU Leuven, leading an academic-industrial project in collaboration with ReGenesys and developing mouse models for hematopoietic cancer research. With a PhD in Biomedical Sciences from KU Leuven (2011) and a Master in Biomedical Sciences from the same institution (2005), Valerie Roobrouck's educational background includes research training at the University of Minnesota as a Research Assistant in 2005.